Dr. Kumardeep Dutta Choudhury
Director Medical Oncology, Cancer Care / Oncology
• DNB (Medical Oncology), Rajiv Gandhi Cancer Institute and Research Centre, Delhi • Training in Medical Oncology from TATA Memorial Hospital, Mumbai • MD (Internal Medicine), Silchar Medical College, Assam • MBBS, Silchar Medical College, Assam
Experience: 19 Years
• DNB (Medical Oncology), Rajiv Gandhi Cancer Institute and Research Centre, Delhi • Training in Medical Oncology from TATA Memorial Hospital, Mumbai • MD (Internal Medicine), Silchar Medical College, Assam • MBBS, Silchar Medical College, Assam
Experience: 19 Years
Languages:
English ,Hindi,Assamese
Medical Oncology
Max Super Speciality Hospital, Shalimar Bagh - New Delhi, India
• Immunotherapy
• Targeted Therapy
• Chemotherapy
• Hormonal Therapy
• Breast cancer
• Lung cancer
• Lymphomas
• GI Cancer
• Epithelial Ovarian Cancer
• American Society of Clinical Oncology
• European Society of Medical Oncology
• Association of Physician of India
• International Association for the Study of Lung Cancer
• Attended various national and international conferences
• Various national and international papers published in his name
• Principal and co-investigator in various clinical trials
• Samita Mishra Memorial Foundation for Cancer Research Excellence Award for Active Role and Leadership in Cancer Bhagao Campaign
2014
• Most Proactive Physician for Adaptation of EHR on 19th Foundation Day at Rajiv Gandhi Cancer Institute
2015
• Bhagirath Samman for Social Work
Delhi
2017-18
• Over 8 lakh deaths due to Colorectal Cancer in 2018. Expert emphasizes the need for more screening programs among high-risk groups. By Dr. Kumardeep Dutta Choudhury
Hindustan Times
2019
• EGFR Mutation in Lung Adenocarcinoma in Indian Subcontinent in Docplexus
2019
• Challenges Associated With Breast Cancer Management in Docplexus
2019